Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours

Technology appraisal guidance
Reference number: TA265
Published: 24 October 2012

TA265 Bone metastases from solid tumours - denosumab: Appendix B proposal paper presented to the Institute's Guidance Executive

TA265 Bone metastases from solid tumours - denosumab: Appendix B proposal paper presented to the Institute's Guidance Executive

TA265 Bone metastases from solid tumours - denosumab: Appendix B proposal paper presented to the Institute's Guidance Executive
29 July 2013
(333.55 Kb 37 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 July 2013